IP Library Granted Patent US 10,702,584
Granted Patent B2
US 10,702,584 · App. 13/806,944 · Granted Jul 7, 2020

Method for preparing a bone protein preparation and a bone protein preparation

Inventors: Hanna Tölli (Reisjärvi, FI); Juha-Matti Närhi (Lempäälä, FI); Harri Lumme (Oulu, FI); Elli Birr (Kempele, FI); Oili Hietala (Oulu, FI); Mikko Viitanen (Oulu, FI); Merja Haikola (Raisio, FI); Pekka Jalovaara (Oulu, FI); Bo Kenneth Sandström (Turku, FI)
Assignee: BBS-BIOACTIVE BONE SUBSTITUTES OYJ
A61K38/1875A61K9/1676A61K35/32A61K38/1709A61K38/1738A61K38/1841A61K38/39A61K38/44A61K38/4833A61L27/365A61L27/3608A61L27/3687A61L2300/252A61L2430/02
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,702,584
App. No.
13/806,944
Granted
Jul 7, 2020
Kind
B2
Abstract

The present invention provides a method for preparing a bone protein preparation which contains for example growth factors. The present invention also provides a bone protein preparation obtained by the method and paste, putty, pellet, disc, block, granule, osteogenic device or pharmaceutical composition containing said bone protein preparation.

Claims (23)

1. A bone preparation comprising a reindeer bone protein extract, polyethylene glycol, glycerol, and calcium salt granules, wherein the reindeer bone protein extract comprises Matrix Gla protein, a species of SPP-24 (secreted phosphoprotein), which migrates on SDS-PAGE at approximately 15 kDa, BMP-2, BMP-7, and TGF-beta 1.

2. The bone preparation of claim 1 , wherein the reindeer bone protein extract further comprises at least one of the following: a species of biglycan, which migrates at approximately 15 kDa on SDS-PAGE or a species of chondroadherin, which migrates at approximately 15 kDa on SDS-PAGE.

3. The bone protein preparation of claim 1 , wherein the bone protein preparation is in a form of a lyophilizate.

4. The bone protein preparation of claim 1 , wherein the calcium salt granules comprise β-tricalcium phosphate (TCP).

5. The bone protein preparation of claim 1 , wherein the calcium salt granules comprise calcium sulfate (CS).

6. The bone protein preparation of claim 1 , wherein the calcium salt granules comprise hydroxyapatite (HAP).

7. The bone protein preparation of claim 1 , wherein the calcium salt granules are a composite comprising HAP, TCP, and CS.

8. The bone protein preparation of claim 1 , wherein said bone preparation is formulated into a paste or a putty.

9. An osteogenic device comprising the bone preparation of claim 1 .

10. The bone protein preparation of claim 1 , wherein the calcium salt granules are between 300-1000 μm in diameter.

11. The bone protein preparation of claim 1 , wherein the calcium salt granules are between 300-500 μm in diameter.

12. The bone protein preparation of claim 1 , wherein the calcium salt granules are between 500-1000 μm in diameter.

13. A reindeer bone protein guanidine hydrochloride extract having a pH measured between 3.9-4.5, wherein said reindeer bone protein guanidine hydrochloride extract comprises Matrix Gla protein, a species of SPP-24 (secreted phosphoprotein), which migrates on SDS-PAGE at approximately 15 kDa, BMP-2, BMP-7 and TGF-beta 1.

14. The reindeer bone protein guanidine hydrochloride extract of claim 13 , wherein the total protein concentration of the reindeer bone protein guanidine hydrochloride extract, as determined by the Bradford Method, is 0.56 mg/ml±10%.

15. The reindeer bone protein guanidine hydrochloride extract of claim 13 , wherein the reindeer bone protein guanidine hydrochloride extract is subsequently concentrated, dialyzed, and combined with polyethylene glycol, glycerol, and calcium salt granules to form a bone protein preparation.

16. The reindeer bone protein guanidine hydrochloride extract of claim 15 , wherein the reindeer bone protein guanidine hydrochloride extract is concentrated, dialyzed in water forming a first precipitate, re-dissolved in guanidine hydrochloride, and dialyzed in citrate buffer to form a second precipitate.

17. The reindeer bone protein guanidine hydrochloride extract of claim 16 , wherein the second precipitate is subsequently lyophilized.

18. The reindeer bone protein guanidine hydrochloride extract of claim 13 further comprising at least one of the following: biglycan, thrombin, lamin A/C, vimentin, chondroadherin, 22K extracellular matrix protein, lysyl oxidase, osteonectin, collagen, dermatopontin, vitronectin, thrombospondin, vitrin, or pigment epithelium-derived factor.

19. A reindeer bone protein guanidine hydrochloride extract comprising a species of SPP-24 (secreted phosphoprotein), which migrates on SDS-PAGE at approximately 15 kDa.

20. The reindeer bone protein guanidine hydrochloride extract of claim 19 , wherein said reindeer bone protein guanidine hydrochloride extract is combined with polyethylene glycol, glycerol, and calcium salt granules.

21. The reindeer bone protein guanidine hydrochloride extract of claim 19 , further comprising a species of biglycan, which migrates at approximately 15 kDa on SDS-PAGE.

22. The reindeer bone protein guanidine hydrochloride extract of claim 19 , further comprising a species of chondroadherin, which migrates at approximately 15 kDa on SDS-PAGE.

23. The reindeer bone protein guanidine hydrochloride extract of claim 21 , further comprising a species of chondroadherin, which migrates at approximately 15 kDa on SDS-PAGE.

Assignments (2)
CHANGE OF NAME Recorded Feb 5, 2020
From: BBS-BIOACTIVE BONE SUBSTITUTES OY
To: BBS-BIOACTIVE BONE SUBSTITUTES OYJ
Reel/Frame 051831/0412 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 22, 2013
From: TOLLI, HANNA; NARHI, JUHA-MATTI; LUMME, HARRI; BIRR, ELLI; HIETALA, OILI; VIITANEN, MIKKO; HAIKOLA, MERJA; JALOVAARA, PEKKA; SANDSTROM, BO KENNETH
To: BBS-BIOACTIVE BONE SUBSTITUTES OY
Reel/Frame 030468/0428 →
Priority Claims (2)
EP 10167448 · Jun 28, 2010 · regional
EP 11160828 · Apr 1, 2011 · regional
Continuity (1)
Related Publication 20150202265A1 · Jul 23, 2015